Torin 1

Catalog No.S2827

Torin 1 is a potent inhibitor of mTORC1/2 with IC50 of 2 nM/10 nM in cell-free assays; exhibits 1000-fold selectivity for mTOR than PI3K.

Price Stock Quantity  
USD 170 In stock
USD 370 In stock
USD 670 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Torin 1 Chemical Structure

Torin 1 Chemical Structure
Molecular Weight: 607.62

Validation & Quality Control

Customer Product Validation(4)

Quality Control & MSDS

Related Compound Libraries

mTOR Inhibitors with Unique Features

Product Information

  • Compare mTOR Inhibitors
    Compare mTOR Products
  • Research Area
  • Combination Therapy
    Combination Therapy

Product Description

Biological Activity

Description Torin 1 is a potent inhibitor of mTORC1/2 with IC50 of 2 nM/10 nM in cell-free assays; exhibits 1000-fold selectivity for mTOR than PI3K.
Targets mTORC1 [1]
(Cell-free assay)
mTOR [2]
(Cell-free assay)
DNA-PK [2]
(Cell-free assay)
mTORC2 [1]
(Cell-free assay)

 View  More

IC50 2 nM 4.32 nM 6.34 nM 10 nM
In vitro Torin1 inhibits phosphorylation of mTORC1 and mTORC2 substrates in cells at concentrations of 2 and 10 nM, respectively. Moreover, Torin1 exhibits 1000-fold selectivity for mTOR over PI3K (EC50 = 1800 nM) and exhibits 100-fold binding selectivity relative to 450 other protein kinases. [1] [2] Torin1 causes cell cycle arrest through a rapamycin-resistant mechanism that is also independent of mTORC2. Torin1 disrupts mTORC1-dependent phenotypes more completely than rapamycin. Rapamycin-resistant functions of mTORC1 are required for cap-dependent translation. [1] In a recent study, it is reported Torin1 increases neurotensin secretion and gene expression through activation of the MEK/ERK/c-Jun pathway in the human endocrine cell line BON. [3]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
ETK-1NX73TWVNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoW3TWM2OD1yLkCwNFMxPiEQvF2=MlvLV2FPT0WU
OCUB-MNV7BemlHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVr4So9FUUN3ME2wMlAxOTl2IN88US=>M2W2fHNCVkeHUh?=
DOHH-2NWDzRZhoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mln2TWM2OD1yLkCwNlI2KM7:TR?=MofZV2FPT0WU
NOS-1Mn;DS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFzEPHVKSzVyPUCuNFAzPDJizszNNYPDeWhTW0GQR1XS
L-363MlTGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmPmTWM2OD1yLkCwNlg1KM7:TR?=MnflV2FPT0WU
RL95-2NXL4[JFZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M17HOWlEPTB;MD6wNFMzKM7:TR?=MlrCV2FPT0WU
BL-70NHfjV2JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVjJR|UxRTBwMECzN|ch|ryPMlPFV2FPT0WU
TGBC1TKBNWS3dopTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWjIT|dIUUN3ME2wMlAxOzd7IN88US=>Mn\PV2FPT0WU
697M1HsPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYLhPGNtUUN3ME2wMlAxPjN2IN88US=>NVv6[IJ3W0GQR1XS
RPMI-8226NF;jU2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVPlOY9iUUN3ME2wMlAxPjVzIN88US=>MoLTV2FPT0WU
BL-41M{jJVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV3KXWN4UUN3ME2wMlAxPjl4IN88US=>NGXHSGlUSU6JRWK=
MRK-nu-1MoPNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVHYR3RDUUN3ME2wMlAxPzB5IN88US=>MX;TRW5ITVJ?
EW-1MoXLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NY\vOZM6UUN3ME2wMlAxPzR7IN88US=>NFTQcFhUSU6JRWK=
EVSA-TNFP0[pBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXLlZ5BiUUN3ME2wMlAxQDl{IN88US=>MUHTRW5ITVJ?
HUTU-80MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mm\UTWM2OD1yLkCwPVI6KM7:TR?=MlTlV2FPT0WU
VA-ES-BJM1vEVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkXSTWM2OD1yLkCwPVg1KM7:TR?=NGnWdFJUSU6JRWK=
GCIYNYTSVmE5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFjw[XdKSzVyPUCuNFExODdizszNNVr4foJRW0GQR1XS
ES6M3y5SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYPJR|UxRTBwMEGwPFMh|ryPNX3Y[|hxW0GQR1XS
NALM-6MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUexOHdrUUN3ME2wMlAyOTB{IN88US=>M33TUHNCVkeHUh?=
LB996-RCCNWK0WmsyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1;sUGlEPTB;MD6wNVE{PyEQvF2=MYfTRW5ITVJ?
EW-16M3\xfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoizTWM2OD1yLkCxNVkzKM7:TR?=NGfxUFhUSU6JRWK=
KALS-1NVHWUHAxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4e4d2lEPTB;MD6wNVE6QCEQvF2=NFXFNXJUSU6JRWK=
OPM-2NWexWIVrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVTDdpMzUUN3ME2wMlAyOjlizszNMYDTRW5ITVJ?
KU812NVzCdItzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUTJR|UxRTBwMEGyPVYh|ryPM4f5UHNCVkeHUh?=
A4-FukM4jHU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWrJR|UxRTBwMEGzNVkh|ryPMmnOV2FPT0WU
KGNNIjYNlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX\JR|UxRTBwMEGzOVkh|ryPMo\oV2FPT0WU
KS-1MmDDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2HUVWlEPTB;MD6wNVM6OiEQvF2=MV7TRW5ITVJ?
no-11MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX\JR|UxRTBwMEGzPVUh|ryPM13BSXNCVkeHUh?=
PSN1MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWjhbI5uUUN3ME2wMlAyPDB7IN88US=>NInZd4lUSU6JRWK=
SK-LMS-1NIHzdXNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnezTWM2OD1yLkCxOFE{KM7:TR?=MX7TRW5ITVJ?
LS-411NM2D5XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYm3dIJGUUN3ME2wMlAyPDN7IN88US=>NXHCbYtXW0GQR1XS
HT-144NF\6bFFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV3JR|UxRTBwMEG0OVEh|ryPMnKwV2FPT0WU
ACNMmDLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2nLdmlEPTB;MD6wNVUh|ryPM3LMbnNCVkeHUh?=
RKOMlT1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHn1TVVKSzVyPUCuNFE2OzNizszNNHHLVZRUSU6JRWK=
CMKNVfDdVhNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2\yPGlEPTB;MD6wNVU1OyEQvF2=MXrTRW5ITVJ?
GB-1NFLyU4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVzJR|UxRTBwMEG1OVMh|ryPMl7rV2FPT0WU
KE-37MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF32c3VKSzVyPUCuNFE2PzNizszNNHj0V3NUSU6JRWK=
no-10NUTMbVdlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHnlZZFKSzVyPUCuNFE2QDRizszNNGXrPFRUSU6JRWK=
MOLT-16M{PMbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUjifWVoUUN3ME2wMlAyPjJ{IN88US=>MV;TRW5ITVJ?
HELMWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4HqRWlEPTB;MD6wNVY1KM7:TR?=NFK0cW1USU6JRWK=
NCI-H1355NXrVOZZ3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1LVbWlEPTB;MD6wNVY1PiEQvF2=MkDlV2FPT0WU
IST-MEL1NIK5RpRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3:3Z2lEPTB;MD6wNVc4PCEQvF2=M2raV3NCVkeHUh?=
MHH-PREB-1M4P5fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVXJR|UxRTBwMEG4NVgh|ryPM{fRTXNCVkeHUh?=
ES8M3HKSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVfaW2h3UUN3ME2wMlAyQDR2IN88US=>NYLDOIFUW0GQR1XS
LC-2-adNXnHPG9uT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MliwTWM2OD1yLkCyNVM4KM7:TR?=MXzTRW5ITVJ?
LAMA-84NX62SmY{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4KwPGlEPTB;MD6wNlE3PyEQvF2=MkXtV2FPT0WU
BV-173MnXpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUL5Uo86UUN3ME2wMlAzOjB|IN88US=>M{\sO3NCVkeHUh?=
SW872NHvQS5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NG\xTpZKSzVyPUCuNFIzPDdizszNNYT5cWtyW0GQR1XS
SK-UT-1NYfCRncxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3TEbGlEPTB;MD6wNlI3OSEQvF2=NU\idnpoW0GQR1XS
OS-RC-2MkHES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYXocZdCUUN3ME2wMlAzOzJ|IN88US=>NXHF[XlFW0GQR1XS
NCI-H747MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF;Je2VKSzVyPUCuNFI{OyEQvF2=MWjTRW5ITVJ?
MZ2-MELNEnQUmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4e0PGlEPTB;MD6wNlM{PyEQvF2=MkjZV2FPT0WU
TE-11MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWLiUWZQUUN3ME2wMlAzOzd{IN88US=>M4[0dHNCVkeHUh?=
KURAMOCHIMU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4T3WGlEPTB;MD6wNlQyPCEQvF2=NIjpd4FUSU6JRWK=
HD-MY-ZNILwdo1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHG1XnRKSzVyPUCuNFI1OjZizszNNUP5WlNsW0GQR1XS
GI-1M{LOcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIjwR|RKSzVyPUCuNFI1PjlizszNNIfKSYNUSU6JRWK=
LB1047-RCCNUTxVFc5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3TPd2lEPTB;MD6wNlQ5QCEQvF2=MoXXV2FPT0WU
TE-12MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHnVO2ZKSzVyPUCuNFI2PSEQvF2=MVLTRW5ITVJ?
MZ7-melM4rBOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{nvT2lEPTB;MD6wNlYxQSEQvF2=NXjTPFJzW0GQR1XS
MMAC-SFMU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUX2do83UUN3ME2wMlAzPjN|IN88US=>MUHTRW5ITVJ?
A101DM2L5V2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH\zTIJKSzVyPUCuNFI3PSEQvF2=MYHTRW5ITVJ?
GR-STM1vyOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWjJR|UxRTBwMEK2OVUh|ryPMV\TRW5ITVJ?
MC116M3TWcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MorYTWM2OD1yLkCyOlgh|ryPNVfMdI9SW0GQR1XS
Ramos-2G6-4C10NUfzdpE5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3TsdmlEPTB;MD6wNlc2KM7:TR?=MUDTRW5ITVJ?
ATN-1MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIPZVWZKSzVyPUCuNFI4QDlizszNM2TSWXNCVkeHUh?=
MFH-inoNI\3dnVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXL1[nJQUUN3ME2wMlAzQDF{IN88US=>MnGyV2FPT0WU
DELNXe2TI1LT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml;oTWM2OD1yLkCyPFE2KM7:TR?=MnG4V2FPT0WU
OCI-AML2M2DMTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYLkOY5tUUN3ME2wMlAzQDdzIN88US=>MVfTRW5ITVJ?
LXF-289MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoHHTWM2OD1yLkCyPFczKM7:TR?=M2fneXNCVkeHUh?=
IA-LMMX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkTPTWM2OD1yLkCyPVE4KM7:TR?=MlOwV2FPT0WU
EoL-1-cellMUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mly5TWM2OD1yLkCyPVk3KM7:TR?=MVjTRW5ITVJ?
OVCAR-4MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIftV3VKSzVyPUCuNFMxQTRizszNNYmwe|VnW0GQR1XS
ES1M3W2TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mo\PTWM2OD1yLkCzNFk4KM7:TR?=M1Lr[3NCVkeHUh?=
CESSNWrvdoxvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV\6NHduUUN3ME2wMlA{ODl7IN88US=>NV;2RoNvW0GQR1XS
GAKMknSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGn5d49KSzVyPUCuNFMyQDZizszNNXrlcnJHW0GQR1XS
NTERA-S-cl-D1M3zBUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIfjN2JKSzVyPUCuNFMzOjZizszNNHPkOm5USU6JRWK=
TE-10M{LZVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mnz0TWM2OD1yLkCzN|EyKM7:TR?=NVnySmkyW0GQR1XS
CCRF-CEMM{W0ZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV3JR|UxRTBwMEOzO|Eh|ryPM4G5N3NCVkeHUh?=
NMC-G1NIrQV|dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXrJR|UxRTBwMEO0OFgh|ryPMXzTRW5ITVJ?
HOP-62NV3MPG1wT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWXJR|UxRTBwMEO1OVYh|ryPMYXTRW5ITVJ?
SH-4NXPXbVh{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVLJfGc{UUN3ME2wMlA{PTh{IN88US=>M{nSOnNCVkeHUh?=
NCI-H1648MmPLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFzXcIhKSzVyPUCuNFM3OjJizszNMlzZV2FPT0WU
EB-3MnzkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{LIe2lEPTB;MD6wN|Y1OyEQvF2=NY\tfFZ7W0GQR1XS
BB65-RCCNUfPZ3FVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWf0R2I2UUN3ME2wMlA{PjlzIN88US=>Mm\FV2FPT0WU
BE-13NHjycZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1\Ve2lEPTB;MD6wN|c2QSEQvF2=NIjnfHRUSU6JRWK=
CP67-MELMlK0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYHJR|UxRTBwMEO3OVkh|ryPNU\xPGVFW0GQR1XS
SW954MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWGxO5h4UUN3ME2wMlA{PzlizszNNHTpOXdUSU6JRWK=
TE-5M1roTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NG\6b4lKSzVyPUCuNFM5PTRizszNMkXNV2FPT0WU
HCE-4M4jsU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoXLTWM2OD1yLkCzPFU2KM7:TR?=M1HxXHNCVkeHUh?=
LC-1FM1fjeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkPXTWM2OD1yLkCzPVg6KM7:TR?=MmDXV2FPT0WU
TK10MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXfJR|UxRTBwMESwNVkh|ryPMlL6V2FPT0WU
SJSA-1M17BOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnnPTWM2OD1yLkC0NVg5KM7:TR?=MmXtV2FPT0WU
DaudiNWHNV4pWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2nh[WlEPTB;MD6wOFIzPSEQvF2=M1:2fHNCVkeHUh?=
SW982M4jnWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVXJR|UxRTBwMESyOFYh|ryPNHWwTGtUSU6JRWK=
SF126NY\s[VRuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWXOdG5oUUN3ME2wMlA1OzZzIN88US=>MlOzV2FPT0WU
TE-15MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4T6XmlEPTB;MD6wOFQ{PSEQvF2=MnTCV2FPT0WU
COLO-684MkX4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH63fndKSzVyPUCuNFQ2PjFizszNNF\LcpVUSU6JRWK=
8-MG-BAMYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4\Nb2lEPTB;MD6wOFYzQSEQvF2=NVLoWIxuW0GQR1XS
NB13M3\JfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MW\JR|UxRTBwMES3O|Yh|ryPM3\wW3NCVkeHUh?=
HCC1599Mnn0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4freGlEPTB;MD6wOFg4QSEQvF2=MkPvV2FPT0WU
SK-PN-DWNVfkOItNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYfJR|UxRTBwMES5OFkh|ryPM1Xte3NCVkeHUh?=
ALL-PONWfmZY1FT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmfpTWM2OD1yLkC0PVU3KM7:TR?=MoLTV2FPT0WU
NB6Ml7WS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4LYcWlEPTB;MD6wOVI4OSEQvF2=MorzV2FPT0WU
IST-SL2MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnXkTWM2OD1yLkC1N|YzKM7:TR?=NHrTU|ZUSU6JRWK=
BB30-HNCNILuOphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUKwXXczUUN3ME2wMlA2PzNizszNM2LpRXNCVkeHUh?=
SW962MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHyzOmNKSzVyPUCuNFU4PjNizszNNYLJXmpxW0GQR1XS
TGBC24TKBMmC2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGnVZ|dKSzVyPUCuNFU4QTlizszNMW\TRW5ITVJ?
KINGS-1NXP4bGozT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnfhTWM2OD1yLkC1PFA{KM7:TR?=NUfaVZpCW0GQR1XS
HC-1Ml;4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVTJR|UxRTBwMEW4Nlch|ryPNX6yOWlMW0GQR1XS
RS4-11MoPNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NITDNWpKSzVyPUCuNFU6OzhizszNM4TpRnNCVkeHUh?=
LS-123NFrTfZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYLJR|UxRTBwMEW5OFIh|ryPNYHCPFl{W0GQR1XS
A3-KAWMlnCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUXJR|UxRTBwME[yNlUh|ryPMVzTRW5ITVJ?
SNB75NVzUSGJZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NISwcW1KSzVyPUCuNFY{PDFizszNM{HoTnNCVkeHUh?=
SRM4PkPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEXHUWRKSzVyPUCuNFY{PzRizszNMX;TRW5ITVJ?
LOUCYM4PXZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnfqTWM2OD1yLkC2N|k1KM7:TR?=MUnTRW5ITVJ?
K5NIDGNVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYjGXmRMUUN3ME2wMlA3PDB|IN88US=>NHX0fG1USU6JRWK=
BeckerNXn2XGtLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYnkdXU4UUN3ME2wMlA3PDJizszNNEHOfVVUSU6JRWK=
CTV-1MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnuzTWM2OD1yLkC2OVQ5KM7:TR?=NYHIcldEW0GQR1XS
KLEM{[0Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYTJR|UxRTBwME[1PFQh|ryPNFnubIJUSU6JRWK=
MZ1-PCNVn0Rm5{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUHGXG5CUUN3ME2wMlA3PTl6IN88US=>NYnBUGZvW0GQR1XS
MOLT-4NEeyOZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml3YTWM2OD1yLkC2OlA2KM7:TR?=NX\6dmdDW0GQR1XS
MLMAMlLmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MU\JR|UxRTBwME[3PEDPxE1?MXPTRW5ITVJ?
A388NXzIN5ppT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVTJR|UxRTBwME[4PVMh|ryPMUjTRW5ITVJ?
MV-4-11NX3DNW8xT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWHy[HJSUUN3ME2wMlA3QTl3IN88US=>MX;TRW5ITVJ?
DSH1M1;BWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoPjTWM2OD1yLkC3NVc{KM7:TR?=MVHTRW5ITVJ?
MONO-MAC-6M2C5NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mnm1TWM2OD1yLkC3NlEzKM7:TR?=NHzBSJRUSU6JRWK=
ARH-77NGPncoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF;uUZNKSzVyPUCuNFczPzhizszNMnTDV2FPT0WU
LB771-HNCNFzTcGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M17CUGlEPTB;MD6wO|U1QSEQvF2=NH3t[HlUSU6JRWK=
PF-382NEPPSlVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWjzell{UUN3ME2wMlA4PTZ7IN88US=>NHK3TpdUSU6JRWK=
KM12NVfqT2ZXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYP3VXZYUUN3ME2wMlA4PjRizszNMVLTRW5ITVJ?
HAL-01NHvxbZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2HNSmlEPTB;MD6wO|Y2QCEQvF2=MlzWV2FPT0WU
RPMI-8402MmjkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoWyTWM2OD1yLkC3O|g6KM7:TR?=NH\sb|lUSU6JRWK=
OMC-1NITPcmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHWwcXpKSzVyPUCuNFc5ODRizszNM2X5bXNCVkeHUh?=
HTMUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2HCUWlEPTB;MD6wPEDPxE1?M3PNe3NCVkeHUh?=
QIMR-WILM4G3c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXfFOHFZUUN3ME2wMlA5ODV3IN88US=>MXnTRW5ITVJ?
KNS-42NV6xUW5XT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEDHVGhKSzVyPUCuNFgzODNizszNMmH4V2FPT0WU
BC-3NWTlS5BQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGm5eotKSzVyPUCuNFgzODRizszNM{X2Z3NCVkeHUh?=
ES4NWjYNG5tT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnTqTWM2OD1yLkC4Nlk3KM7:TR?=MlPGV2FPT0WU
NCI-H23NIr1b25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVzJR|UxRTBwMEi0OEDPxE1?MXnTRW5ITVJ?
LB2518-MELM1XsPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlfwTWM2OD1yLkC4Olk3KM7:TR?=NYjoUVdtW0GQR1XS
LC4-1NFezZ5NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVrMPYEzUUN3ME2wMlA5PzN6IN88US=>NWDXc4ZIW0GQR1XS
SIG-M5MoTmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmLDTWM2OD1yLkC4PVA1KM7:TR?=NI\kWoJUSU6JRWK=
LP-1M2XwNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEfZblJKSzVyPUCuNFg6OzhizszNMU\TRW5ITVJ?
TE-8M37Mc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVPYdWt[UUN3ME2wMlA6ODF4IN88US=>M{fk[nNCVkeHUh?=
K-562NIrJZodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHnzUIpKSzVyPUCuNFkyOiEQvF2=NWDqdG94W0GQR1XS
J-RT3-T3-5MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NE\X[nlKSzVyPUCuNFkyPTNizszNMmTSV2FPT0WU
DU-4475NGfjNppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NI[4eIZKSzVyPUCuNFkyPjVizszNMoXRV2FPT0WU
RXF393NF;2NZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIjnVnFKSzVyPUCuNFk1PjJizszNNWPPblc1W0GQR1XS
NB5NWq2OIFTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2r6PGlEPTB;MD6wPVYzPSEQvF2=MVvTRW5ITVJ?
A704MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVTJR|UxRTBwMEm3OFEh|ryPMWXTRW5ITVJ?
SF268NV3ER2QxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEntbG5KSzVyPUCuNFk5OjVizszNNFnpb|dUSU6JRWK=
UACC-257NGjsWHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3Kx[2lEPTB;MD6wPVg{OyEQvF2=M1Xn[HNCVkeHUh?=
L-428MoDqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmXOTWM2OD1yLkGwN|Ih|ryPNHjreIVUSU6JRWK=
ST486M3rzZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUPwRmNPUUN3ME2wMlExPjB4IN88US=>M3vL[3NCVkeHUh?=
SK-MM-2NUHpXYlpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXnJR|UxRTBwMUC3NFkh|ryPMmLBV2FPT0WU
COR-L279NInQXFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGXJ[I9KSzVyPUCuNVA5OzJizszNMn3IV2FPT0WU
JiyoyeP-2003MnjUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1fBO2lEPTB;MD6xNFg1OyEQvF2=M3nkW3NCVkeHUh?=
GT3TKBMV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUDJR|UxRTBwMUC5NVgh|ryPMXnTRW5ITVJ?
HCE-TMYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX30UGduUUN3ME2wMlExQTRizszNMonGV2FPT0WU
SBC-1M3G0W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUTJR|UxRTBwMUGxNVkh|ryPNH;WWXRUSU6JRWK=
KNS-81-FDNGS4TIZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHfHUHFKSzVyPUCuNVEzPzNizszNNYLZeoo5W0GQR1XS
NCI-H2126M3XOTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoDITWM2OD1yLkGxN|k1KM7:TR?=MWPTRW5ITVJ?
EM-2NV7DSWpyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkDnTWM2OD1yLkGxOVI6KM7:TR?=M13Ie3NCVkeHUh?=
JARMVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3jaWWlEPTB;MD6xNVU6QCEQvF2=NGTsN|NUSU6JRWK=
NB17NHz0O25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHf5WXFKSzVyPUCuNVE3PTJizszNMkLzV2FPT0WU
LB647-SCLCNEPu[oZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnvsTWM2OD1yLkGxO|A2KM7:TR?=NVrLS|Z2W0GQR1XS
CAL-148NUTPUZVlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFvMZ|ZKSzVyPUCuNVE5KM7:TR?=MoTQV2FPT0WU
K052MmX2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MULJR|UxRTBwMUG4OVEh|ryPM4G3OXNCVkeHUh?=
KARPAS-299MlPQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoK1TWM2OD1yLkGyNlM{KM7:TR?=NV[1fmNqW0GQR1XS
KARPAS-422M3TwN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoDJTWM2OD1yLkGyOFMzKM7:TR?=MWTTRW5ITVJ?
LOXIMVIMn7qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV[4foxuUUN3ME2wMlEzPTF3IN88US=>M2XTNnNCVkeHUh?=
SCC-3M{CwS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4rIbmlEPTB;MD6xNlg2OSEQvF2=NVz6S3JXW0GQR1XS
LU-139NV75[WpIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2HrT2lEPTB;MD6xNlk4PSEQvF2=NE\MNm5USU6JRWK=
COLO-320-HSRM1;pS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYK1U4pyUUN3ME2wMlE{ODh4IN88US=>MkPWV2FPT0WU
ONS-76MkLoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFW2dpZKSzVyPUCuNVMyOyEQvF2=MU\TRW5ITVJ?
U-266MoSzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUfJR|UxRTBwMUOyOFUh|ryPM2XPS3NCVkeHUh?=
HHNHT2WppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHLZXIhKSzVyPUCuNVM2OzVizszNMlW5V2FPT0WU
BB49-HNCNYDoVYEzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mn7BTWM2OD1yLkGzOVg4KM7:TR?=MkPTV2FPT0WU
NCI-SNU-5Mkj5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV7Jc3g6UUN3ME2wMlE{PTl4IN88US=>M3LpenNCVkeHUh?=
C2BBe1MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGDud5ZKSzVyPUCuNVM4PDZizszNM{KyVnNCVkeHUh?=
ML-2NYWwfGZpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIrDS2FKSzVyPUCuNVM6PTNizszNNXryfVh4W0GQR1XS
SCHMY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUn4NpNCUUN3ME2wMlE{QTd2IN88US=>NIXxNmNUSU6JRWK=
NCI-H82NXHQbI95T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGHUSFBKSzVyPUCuNVQyODRizszNNVSw[mFpW0GQR1XS
MDA-MB-134-VIMXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml3DTWM2OD1yLkG0NlUzKM7:TR?=MVrTRW5ITVJ?
SK-N-DZMn\nS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1HyVGlEPTB;MD6xOFcyQSEQvF2=MXjTRW5ITVJ?
HL-60NEC0bVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHXFdGFKSzVyPUCuNVQ6OiEQvF2=NFfiWFdUSU6JRWK=
LB373-MEL-DMXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHnTeHdKSzVyPUCuNVU2OzlizszNM4[zUnNCVkeHUh?=
LB831-BLCMYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnrMTWM2OD1yLkG2NFc3KM7:TR?=MmLOV2FPT0WU
SK-NEP-1NX;YOVAzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlzuTWM2OD1yLkG2NVAyKM7:TR?=MYPTRW5ITVJ?
IMR-5MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVX4NItCUUN3ME2wMlE3PDh|IN88US=>MlHGV2FPT0WU
Calu-6MmDzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mom5TWM2OD1yLkG2OVM4KM7:TR?=NY\nUYZOW0GQR1XS
NCI-H1882M2HsTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3TleWlEPTB;MD6xOlczQCEQvF2=M1vVOHNCVkeHUh?=
NCI-H446MmXpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MW\JR|UxRTBwMU[4PVEh|ryPMUPTRW5ITVJ?
GI-ME-NMV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2\FdmlEPTB;MD6xPFAzKM7:TR?=Mn\6V2FPT0WU
MPP-89M37mfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEnhV3RKSzVyPUCuNVgyOjFizszNM4qxVnNCVkeHUh?=
CGTH-W-1NHj3dZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn\ITWM2OD1yLkG4OFM3KM7:TR?=NHGyU3lUSU6JRWK=
MEG-01NWjOVlZ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFrFfnVKSzVyPUCuNVg3OjhizszNNEnBeHZUSU6JRWK=
NCI-H748MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYL2[5Z5UUN3ME2wMlE5QTFzIN88US=>M33UdnNCVkeHUh?=
COLO-829MlnMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4HG[GlEPTB;MD6yNFY4OyEQvF2=MmDkV2FPT0WU
GOTOM{juSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NITBfWZKSzVyPUCuNlA4OyEQvF2=MVLTRW5ITVJ?
EW-3MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml\jTWM2OD1yLkKxO|E5KM7:TR?=M2fuXHNCVkeHUh?=
KY821MlfnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NU\MW2pyUUN3ME2wMlIzODR3IN88US=>M2\qNnNCVkeHUh?=
CTB-1NIL2PGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEn4eWFKSzVyPUCuNlIzOjhizszNMYnTRW5ITVJ?
TALL-1Mni5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NILBT45KSzVyPUCuNlI6OjFizszNM3WwWnNCVkeHUh?=
NCI-H209Mo\oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYfJR|UxRTBwMkK5OlIh|ryPM3rVT3NCVkeHUh?=
IST-MES1Ml\jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mlq2TWM2OD1yLkKzOVEh|ryPMWjTRW5ITVJ?
DMS-114MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUfJR|UxRTBwMkO5PVMh|ryPMV\TRW5ITVJ?
SNU-C2BMmTuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1\Ib2lEPTB;MD6yOFMyPiEQvF2=NIriRpBUSU6JRWK=
DG-75NXnJd2J6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXfsRXA{UUN3ME2wMlI3OTl3IN88US=>Mn;aV2FPT0WU
D-336MGNUHn[3V3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2DXV2lEPTB;MD6yOlU2PyEQvF2=NGTSRmdUSU6JRWK=
KMOE-2MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mnn3TWM2OD1yLkK3OVM5KM7:TR?=NFG5U3lUSU6JRWK=
NB1NF;YVWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWHKfo5SUUN3ME2wMlI4QTJ4IN88US=>NFTKPGxUSU6JRWK=
RH-1NGfLdJpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYPJR|UxRTBwMke5PFkh|ryPMlXWV2FPT0WU
TE-1NXvGWIxCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWHpVVd[UUN3ME2wMlI5PDd7IN88US=>M3\ORXNCVkeHUh?=
RPMI-6666MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkLiTWM2OD1yLkK4PFQh|ryPMkHuV2FPT0WU
TE-9M4nkVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXfQXI53UUN3ME2wMlI5QTh3IN88US=>MWHTRW5ITVJ?
BT-474MoXZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVnJR|UxRTBwMkmzN|Qh|ryPMmfuV2FPT0WU
COLO-668MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXTzcZJUUUN3ME2wMlI6PDJ7IN88US=>NHr5cnBUSU6JRWK=
NCI-H1581MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWnJR|UxRTBwMkm2PFkh|ryPM3i4bnNCVkeHUh?=
MN-60NG\LXGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NELnW4lKSzVyPUCuNlk6ODVizszNMVrTRW5ITVJ?
L-540MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXflXGxmUUN3ME2wMlMxODhzIN88US=>NELaNllUSU6JRWK=
MOLT-13NEXLcmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXrJR|UxRTBwM{CxPFMh|ryPNUPFcpZVW0GQR1XS
NCI-SNU-16NXn4[GJTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV3JR|UxRTBwM{CyNFUh|ryPNV;RVng2W0GQR1XS
NCI-H64M3Tab2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHq1PZpKSzVyPUCuN|A{OzFizszNM2HsV3NCVkeHUh?=
CP66-MELMVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1LQWGlEPTB;MD6zNVQyPSEQvF2=M1\COHNCVkeHUh?=
NB69MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4XVVmlEPTB;MD6zNlE5QCEQvF2=NWHv[4lkW0GQR1XS
NCI-H2196NX[4SnFXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVzJR|UxRTBwM{OwN|Yh|ryPMlLqV2FPT0WU
MHH-CALL-2MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnnMTWM2OD1yLkOzOFY5KM7:TR?=NXTmRlBDW0GQR1XS
HCC2157MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mkf1TWM2OD1yLkOzPVU1KM7:TR?=M13vN3NCVkeHUh?=
LS-1034NXSyNot7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEH6UGVKSzVyPUCuN|Y{QDhizszNNWHjUGgxW0GQR1XS
BOKUMkTBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3rQRWlEPTB;MD6zO|E6QSEQvF2=MmrFV2FPT0WU
GDM-1MmfYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{LROGlEPTB;MD6zO|I{PCEQvF2=NYezdmt5W0GQR1XS
TGWMmHtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFPScY1KSzVyPUCuN|c1PTNizszNM{DIU3NCVkeHUh?=
SNU-C1M2\mT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M37MOGlEPTB;MD6zPFIyPSEQvF2=M4Dk[XNCVkeHUh?=
LS-513M2LvfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnfjTWM2OD1yLkO5NFcyKM7:TR?=MlKxV2FPT0WU
NOMO-1NX;qdJl{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHTG[WZKSzVyPUCuN|k6PzFizszNMWLTRW5ITVJ?
MS-1MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn;6TWM2OD1yLkSwNVc4KM7:TR?=MYLTRW5ITVJ?
EKVXM3TtN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2XnV2lEPTB;MD60OFQ3OSEQvF2=Mn\YV2FPT0WU
SK-MEL-2M4Dpdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3vi[mlEPTB;MD60OlQh|ryPMVfTRW5ITVJ?
HCC1187MmfjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkPETWM2OD1yLkS2O|Y5KM7:TR?=NIHJXndUSU6JRWK=
HCC2218MlXDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlnMTWM2OD1yLkS3NlI4KM7:TR?=NIPHOmpUSU6JRWK=
NCI-H187M3vzdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV;XfotYUUN3ME2wMlQ4QDRizszNM1rQdHNCVkeHUh?=
DBMU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXjJR|UxRTBwNUCwOVUh|ryPMoSxV2FPT0WU
NCI-H69M2rL[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV7vbmtbUUN3ME2wMlUxOjR5IN88US=>NESx[WNUSU6JRWK=
NCI-H1694NGjTRm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYDJR|UxRTBwNUC2PVch|ryPNGH5eY9USU6JRWK=
CA46M4focmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYHrOmF7UUN3ME2wMlUxQTF5IN88US=>NV\neXhlW0GQR1XS
EHEBMXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnjWTWM2OD1yLkWxNVk{KM7:TR?=NH\DTlRUSU6JRWK=
NCCITNUjPWGQ3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{f4R2lEPTB;MD61OFMzOSEQvF2=MnvMV2FPT0WU
NCI-H720NXLjVFNKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIHwUo9KSzVyPUCuOVQ6PjJizszNNEHPcYdUSU6JRWK=
LU-134-ANXzlXoZLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3PjWmlEPTB;MD61OVI6PiEQvF2=MoHGV2FPT0WU
MC-CARNGK4TWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1TLfmlEPTB;MD61OVQ{OSEQvF2=MYTTRW5ITVJ?
NEC8MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3znRWlEPTB;MD61OlE4OiEQvF2=M3nhNHNCVkeHUh?=
NCI-H524MoXGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXfJR|UxRTBwNUi3OFgh|ryPNGPvcnpUSU6JRWK=
NCI-H1963MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3vwV2lEPTB;MD62NlU5KM7:TR?=MlrMV2FPT0WU
SU-DHL-1NWPmVYZMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEPWcoxKSzVyPUCuOlQ2OjZizszNNY\NbIFEW0GQR1XS
NCI-H1522NVP5RpVoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnjTTWM2OD1yLk[0PFg{KM7:TR?=MYDTRW5ITVJ?
NCI-H1155NHfR[JlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M360OWlEPTB;MD62OVM2KM7:TR?=M1\jS3NCVkeHUh?=
D-263MGMUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVzpXphoUUN3ME2wMlY3OTBzIN88US=>NVzLZ|MxW0GQR1XS
TE-6Ml7DS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUHJR|UxRTBwNkixNFQh|ryPMl;iV2FPT0WU
NCI-H1417MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYHHWW5zUUN3ME2wMlY6PzFzIN88US=>NFTQd2VUSU6JRWK=
NCI-H510ANF3ldoVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYj0[YpuUUN3ME2wMlc4OjN4IN88US=>NXPZdHE6W0GQR1XS
KARPAS-45M2jGOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4rweGlEPTB;MD63PFI{PSEQvF2=NUDpR49EW0GQR1XS
IST-SL1M{ixTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIDpepNKSzVyPUCuPFU5OjVizszNMVvTRW5ITVJ?
COLO-824MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{S4NWlEPTB;MD64O|g{PSEQvF2=NIPuZWJUSU6JRWK=
NCI-H526NVLsXZFJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoLxTWM2OD1yLkmwPVU5KM7:TR?=MkjQV2FPT0WU
NCI-H719NXXhXGhyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmTKTWM2OD1yLkm2OlU4KM7:TR?=NUjG[ZlyW0GQR1XS
SF539MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUXJR|UxRTBwOUizPVYh|ryPM2[3UHNCVkeHUh?=
NKM-1NXPIVmlVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{fZUmlEPTB;MD65PFY3OyEQvF2=NF3uPGVUSU6JRWK=
A253NFXCfoxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEjmRlBKSzVyPUCuPVg5QDVizszNMl;NV2FPT0WU
TE-441-TNEfhZpZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWjiOoxiUUN3ME2xMlA1OzVizszNM2jnNXNCVkeHUh?=
COR-L88MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYH0c2l7UUN3ME2xMlEyOzV2IN88US=>MYjTRW5ITVJ?
CPC-NMkXTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWnJR|UxRTFwMUW4PFgh|ryPNVq4c4pjW0GQR1XS
NCI-H2107NEfIcnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVrJR|UxRTFwMUeyOlEh|ryPMn\ZV2FPT0WU
ECC4NITCT3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUDEOnFCUUN3ME2xMlE5Pjl|IN88US=>NVOyVo9NW0GQR1XS
NCI-H2141NUTZUmdsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MorTTWM2OD1zLkG5Nlk6KM7:TR?=NYnRV251W0GQR1XS
NCI-H1770NIXYTY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYjJR|UxRTFwM{K5Nlgh|ryPNXrWZ5o4W0GQR1XS
NCI-SNU-1Ml\2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3S5WmlEPTB;MT6zN|A1KM7:TR?=M{XJ[HNCVkeHUh?=
LU-165MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYHJR|UxRTFwNEW0Olch|ryPMmD5V2FPT0WU
RajiMVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUHue252UUN3ME2xMlQ4OjV7IN88US=>M1nKWnNCVkeHUh?=
EW-24NY[wfnJPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHi4dZJKSzVyPUGuOVQ3OTlizszNMX7TRW5ITVJ?
KP-N-RT-BM-1MkfBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEXOUnhKSzVyPUGuOVY2PTFizszNMmfsV2FPT0WU
SK-MEL-1NF\3SplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnvmTWM2OD1zLk[0PFc4KM7:TR?=MXzTRW5ITVJ?
SCLC-21HNIfORY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGe5cWtKSzVyPUGuOlY3PTFizszNMoHLV2FPT0WU
SIMANWG3SodiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH;wUnpKSzVyPUGuOlgzOzNizszNMn\IV2FPT0WU
NCI-H1304MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHm0PHNKSzVyPUGuO|A4PjVizszNNF\BfGpUSU6JRWK=
REHMk\VS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEPGZoVKSzVyPUGuO|ExPzhizszNMm\CV2FPT0WU
KP-N-YSNUm2PJRbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1vkXmlEPTB;MT65N|U2OSEQvF2=NFLRT2hUSU6JRWK=
DMS-153NFLQTYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnjMTWM2OD1zLkm3OVkh|ryPM2n3NHNCVkeHUh?=
NB10NYrBUndoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIe4NZZKSzVyPUKuNlA5PzhizszNNF6yNnZUSU6JRWK=
NCI-H345Mn6yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYHJR|UxRTJwNkG5NFUh|ryPMWDTRW5ITVJ?
SK-N-FIM{LtTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4LEdGlEPTB;Mj63OVM5OSEQvF2=M3jOXXNCVkeHUh?=
NCI-H1092NVz2VJY6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4e3T2lEPTB;Mj65OVM6PCEQvF2=MnP3V2FPT0WU
KM-H2NWTvd2FnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGf4VWtKSzVyPUOuOlU{QTZizszNM4rXdnNCVkeHUh?=
KG-1MojDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4Xvb2lEPTB;Mz63NVY5QCEQvF2=MkLnV2FPT0WU
D-283MEDM4nudWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NU\L[nBEUUN3ME2zMlc2QDdizszNM37BV3NCVkeHUh?=
LU-65NFn6UZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2LGZ2lEPTB;ND6xNVQ5PSEQvF2=Mlr5V2FPT0WU
MSTO-211HMni2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnTGTWM2OD12LkG4PFk5KM7:TR?=MljBV2FPT0WU
NCI-H2081NH;WfZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHP6d41KSzVyPUSuNlkyPzRizszNMl:4V2FPT0WU
D-247MGNWrUZoxQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmH0TWM2OD12LkSzNVkyKM7:TR?=NF3jVXVUSU6JRWK=
P31-FUJM1LIcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXrJR|UxRTRwNEWwNVkh|ryPNVrJeXpjW0GQR1XS
DMS-79NWHZNY1iT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWTJR|UxRTRwOUOxPFMh|ryPNEHPVo9USU6JRWK=
KASUMI-1NV3xVlcxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlPxTWM2OD12Lkm3OVA6KM7:TR?=MkfUV2FPT0WU
JVM-3NVzadXAxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkTpTWM2OD13LkK1NFE1KM7:TR?=NUfsWoNPW0GQR1XS
LAN-6MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1j1SmlEPTB;NT61NVc{PiEQvF2=M4fOT3NCVkeHUh?=
DJM-1MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mmj6TWM2OD13LkW2NFI6KM7:TR?=NF\MUGNUSU6JRWK=
JVM-2MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGKwNGlKSzVyPUWuOlcxQTJizszNMlXRV2FPT0WU
U-87-MGM3;v[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXPJR|UxRTVwOEm5OlQh|ryPNUfhbpF7W0GQR1XS
SHP-77MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXHCNFNSUUN3ME21Mlk1QTJ6IN88US=>M2LoZ3NCVkeHUh?=
RPMI-8866MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MY\JR|UxRTZwMkewNVMh|ryPNUXn[m1uW0GQR1XS
ES7MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEPTO2VKSzVyPU[uN|k6OjRizszNMny3V2FPT0WU
WSU-NHLNFracJNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX7JR|UxRTZwNUG2NFkh|ryPNEHpb|VUSU6JRWK=
CAS-1NGOzcXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2nnfmlEPTB;Nz6wPVc1QSEQvF2=MYfTRW5ITVJ?
MHH-NB-11MmLBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUfJR|UxRThwMkOxOVIh|ryPM1KyeXNCVkeHUh?=
ES5NXi0SlVIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGPUc5VKSzVyPUmuOVIzQDZizszNNFviWFFUSU6JRWK=
HDLM-2MmXiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF[xZ5lKSzVyPUmuPVU6ODJizszNNWTCUlBvW0GQR1XS
NCI-H2171M1W2emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{LsfmlEPTB;MUCuOVkzPyEQvF2=MlX6V2FPT0WU
LNCaP-Clone-FGCNYK4VWRiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYrJR|UxRTFzLkO3NVgh|ryPMkPnV2FPT0WU
NCI-H1395NHu4eZVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mk\xTWM2OD1zMj6yOlk6KM7:TR?=NVLsSmlLW0GQR1XS
NCI-H1436NGDpenVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3fCbGlEPTB;MUOuN|E6PSEQvF2=MYfTRW5ITVJ?
RCC10RGBNF6wTJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF7WW2pKSzVyPUGzMlMzOjFizszNMXrTRW5ITVJ?
SW684NGHZVoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmPtTWM2OD1zMz65O|k4KM7:TR?=NE\YU|lUSU6JRWK=
NCI-H1650NFvl[HlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlHsTWM2OD1zNT6wOFQ4KM7:TR?=NEHDV5hUSU6JRWK=
EW-13MoDVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1jOfmlEPTB;MUWuNlAzOSEQvF2=MmjwV2FPT0WU
EC-GI-10NYr4cYFoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{P6TGlEPTB;MUWuPFY1PCEQvF2=NV;RcmN3W0GQR1XS
CHP-126MlX2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYfJR|UxRTF5LkG5NVgh|ryPNHK3bINUSU6JRWK=
NCI-H226MnjDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWjJR|UxRTF6LkC0NFMh|ryPNVPNcYdoW0GQR1XS
NCI-H1838Mni1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFzCelNKSzVyPUKwMlE5PDhizszNMlTEV2FPT0WU
EW-11M3vNVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXPheGM1UUN3ME2yOE4zPzF6IN88US=>MW\TRW5ITVJ?
EB2NEm2NYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1rx[mlEPTB;M{GuOVMyQCEQvF2=NUDFNpJUW0GQR1XS
D-502MGM3XIeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mlv5TWM2OD12Mz65NlI6KM7:TR?=Mn7sV2FPT0WU
U-698-MMWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M33xeGlEPTB;NEiuPFY4OSEQvF2=Mk\0V2FPT0WU
ES3M1[y[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnjlTWM2OD12OT6zPFk{KM7:TR?=M1LtT3NCVkeHUh?=

... Click to View More Cell Line Experimental Data

In vivo Torin1 is efficacious at a dose of 20 mg/kg in a U87MG xenograft model and demonstrates good pharmacodynamic inhibition of downstream effectors of mTOR in tumor and peripheral tissues. [2]
Features

Protocol(Only for Reference)

Kinase Assay: [1]

mTORC1 and mTORC2 in Vitro Kinase Assays To produce soluble mTORC1, HEK-293T cell lines that stably express N-terminally FLAG-tagged Raptor are generated using vesicular stomatitis virus G-pseudotyped MSCV retrovirus. For mTORC2, similar HeLa cells that stably express N-terminally FLAG-tagged Protor-1 are generated. Both complexes are purified by lysing cells in 50 mm HEPES, pH 7.4, 10 mm sodium pyrophosphate, 10 mm sodium β-glycerophosphate, 100 mm NaCl, 2 mm EDTA, 0.3% CHAPS. Cells are lysed at 4 °C for 30 min, and the insoluble fraction is removed by microcentrifugation at 13,000 rpm for 10 min. Supernatants are incubated with FLAG-M2 monoclonal antibody-agarose for 1 h and then washed three times with lysis buffer and once with lysis buffer containing a final concentration of 0.5 M NaCl. Purified mTORC1 is eluted with 100 μg/mL 3×FLAG peptide in 50 mm HEPES, pH 7.4, 100 mm NaCl. Eluate can be aliquoted and stored at -80 °C. Substrates S6K1 and Akt1 are purified. Kinase assays are performed for 20 min at 30 °C in a final volume of 20 μL consisting of the kinase buffer (25 mm HEPES, pH 7.4, 50 mm KCl, 10 mm MgCl2, 500 μm ATP) and 150 ng of inactive S6K1 or Akt1 as substrates. Reactions are stopped by the addition of 80 μL of sample buffer and boiled for 5 min. Samples are subsequently analyzed by SDS-PAGE and immunoblotting.

Cell Assay: [1]

Cell lines MEFs
Concentrations ~250 nM
Incubation Time 4 days
Method Cell viability is assessed with the CellTiter-Glo Luminescent Cell Viability Assay. On Day 0, 96-well plates are seeded with 500 cells per well and grown overnight. On Day 1, cells are treated with the appropriate compounds and subsequently analyzed on Days 3-5. For analysis, plates are incubated for 60 min at room temperature; 50 μL of CellTiter-Glo reagent is added to each well, and plates are mixed on an orbital shaker for 12 min. Luminescence is quantified on a standard plate luminometer.

Animal Study: [2]

Animal Models U87MG xenograft model
Formulation Torin1 powder is first dissolved at 25 mg/mL in 100% N-methyl-2-pyrrolidone and subsequently diluted 1:4 with sterile 50% PEG400 to a final concentration of 5 mg/mL
Dosages 20 mg/kg
Administration Administered via i.p. once daily

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Thoreen CC, et al, J Biol Chem, 2009, 284(12), 8023-8032.

[2] Liu Q, et al, J Med Chem, 2010, 53(19), 7146-7155.

view more

Chemical Information

Download Torin 1 SDF
Molecular Weight (MW) 607.62
Formula

C35H28F3N5O2

CAS No. 1222998-36-8
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 2 mg/mL (3.29 mM)
Water <1 mg/mL (<1 mM)
Ethanol <1 mg/mL (<1 mM)
In vivo 30% PEG 400+0.5% Tween80+5% Propylene glycol 30mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name Benzo[h]-1,6-naphthyridin-2(1H)-one, 1-[4-[4-(1-oxopropyl)-1-piperazinyl]-3-(trifluoromethyl)phenyl]-9-(3-quinolinyl)-

Customer Product Validation (4)


Click to enlarge
Rating
Source Mol Cell Biol 2014 34(24), 4474-84. Torin 1 purchased from Selleck
Method Immunoprecipitation
Cell Lines HeLa cells
Concentrations 1 mM
Incubation Time 1 h
Results The specificity of the reaction was further demonstrated by the loss of SENP3 phosphorylation as well as mTOR autophosphorylation upon the addition of the mTOR inhibitor Torin1.

Click to enlarge
Rating
Source Am J Pathol 2014 184(1), 214-29. Torin 1 purchased from Selleck
Method Western blot
Cell Lines Huh-7.5 cells
Concentrations 0-100 nM
Incubation Time 24 h
Results To investigate the relationship between ER stress and autophagy and IFN receptors, it first induced ER stress and autophagy response with the known inducers TG and Torin 1, respectively, in uninfected Huh-7.5 cells. It performed TG and Torin 1 titration experiments in HCV-infected and uninfected Huh-7.5 cells to compare IFNAR1 expression by Western blotting.

Click to enlarge
Rating
Source Biochem Biophys Res Commun 2014 10.1016/j.bbrc.2014.05.047. Torin 1 purchased from Selleck
Method Western blot
Cell Lines HepG2 cells
Concentrations 0.1 nM
Incubation Time 24 h
Results When autophagy was induced by treatment of mTOR inhibitors PP242 or Torin1, the amount of LC3-II increased.

Click to enlarge
Rating
Source Lim Hsiu Kim, Lina from National University of Singapore. Torin 1 purchased from Selleck
Method ELISA
Cell Lines C6
Concentrations 10 nM
Incubation Time 1 h
Results

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related mTOR Products

  • MHY1485

    MHY1485 is a potent, and cell-permeable mTOR activator, and also potently inhibits autophagy.

  • CHIR-99021 (CT99021)

    CHIR-99021 (CT99021) is a GSK-3α and GSK-3β inhibitor with IC50 of 10 nM and 6.7 nM, respectively.

  • Dorsomorphin

    Dorsomorphin is a potent, reversible, selective AMPK inhibitor with Ki of 109 nM in cell-free assays, exhibiting no significant inhibition of several structurally related kinases including ZAPK, SYK, PKCθ, PKA, and JAK3. Also inhibits type I BMP receptor activity.

  • Rapamycin (Sirolimus)

    Rapamycin (Sirolimus) is a specific mTOR inhibitor with IC50 of ~0.1 nM HEK293 cells.

  • Everolimus (RAD001)

    Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM in a cell-free assay.

  • AZD8055

    AZD8055 is a novel ATP-competitive mTOR inhibitor with IC50 of 0.8 nM in MDA-MB-468 cells with excellent selectivity (∼1,000-fold) against PI3K isoforms and ATM/DNA-PK. Phase 1.

    Features:First drug to inhibit both types of mTOR protein.

  • Temsirolimus (CCI-779, NSC 683864)

    Temsirolimus (CCI-779, NSC 683864) is a specific mTOR inhibitor with IC50 of 1.76 μM in a cell-free assay.

  • INK 128 (MLN0128)

    INK 128 (MLN0128) is a potent and selective mTOR inhibitor with IC50 of 1 nM in cell-free assays; >200-fold less potent to class I PI3K isoforms, superior in blocking mTORC1/2 and sensitive to pro-invasion genes (vs Rapamycin). Phase 1.

  • Tacrolimus (FK506)

    Tacrolimus (FK506) is a 23-membered macrolide lactone, it reduces peptidyl-prolyl isomerase activity in T cells by binding to the immunophilin FKBP12 (FK506 binding protein) creating a new complex.

  • KU-0063794

    KU-0063794 is a potent and highly specific dual-mTOR inhibitor of mTORC1 and mTORC2 with IC50 of ~10 nM in cell-free assays; no effect on PI3Ks.

Recently Viewed Items

Tags: buy Torin 1 | Torin 1 supplier | purchase Torin 1 | Torin 1 cost | Torin 1 manufacturer | order Torin 1 | Torin 1 distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us